Cadence Bank NA’s GSK GSK Stock Holding History

Cadence Bank NA’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,178	Closed	-$445K	–	99
2022 Q2	$445K	Hold	8,178	–	–	0.14%	134
2022 Q1	$445K	Hold	8,178	–	–	0.12%	139
2021 Q4	$451K	Hold	8,178	–	–	0.12%	139
2021 Q3	$391K	Buy	8,178 +63	+0.8%	+$3.16K	0.12%	143
2021 Q2	$404K	Hold	8,115	–	–	0.12%	145
2021 Q1	$362K	Buy	8,115 +80	+1%	+$3.63K	0.11%	154
2020 Q4	$370K	Sell	8,035 -9,484	-54%	-$436K	0.13%	140
2020 Q3	$824K	Buy	17,519 +1,073	+7%	+$53.8K	0.32%	79
2020 Q2	$839K	Buy	16,446 +647	+4%	+$33.2K	0.35%	73
2020 Q1	$748K	Buy	15,799 +5,820	+58%	+$310K	0.38%	69
2019 Q4	$586K	Buy	9,979 +2,111	+27%	+$117K	0.22%	115
2019 Q3	$420K	Buy	7,868 +155	+2%	+$7.97K	0.16%	130
2019 Q2	$386K	Buy	7,713 +21	+0.3%	+$1.05K	0.15%	138
2019 Q1	$401K	Sell	7,692 -117	-1%	-$5.85K	0.16%	129
2018 Q4	$373K	Buy	+7,809	New	+$385K	0.17%	122
2017 Q3	–	Sell	-4,369	Closed	-$236K	–	176
2017 Q2	$236K	Sell	4,369 -753	-15%	-$40.1K	0.11%	124
2017 Q1	$269K	Sell	5,122 -1,903	-27%	-$96.5K	0.12%	111
2016 Q4	$339K	Sell	7,025 -21	-0.3%	-$1.04K	0.16%	97
2016 Q3	$380K	Sell	7,046 -38	-0.5%	-$2.08K	0.17%	87
2016 Q2	$384K	Buy	7,084 +1,202	+20%	+$63.3K	0.19%	87
2016 Q1	$298K	Buy	+5,882	New	+$293K	0.15%	103
2015 Q4	–	Sell	-4,360	Closed	-$210K	–	137
2015 Q3	$210K	Buy	4,360 +281	+7%	+$14.6K	0.12%	118
2015 Q2	$212K	Buy	+4,079	New	+$230K	0.14%	120

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cadence Bank NA's GSK Position: Q3 2022 in Review

Cadence Bank NA sold out of GSK (GSK) in Q3 2022, closing a stake of 8,178 shares — an estimated $445K sold.

Cadence Bank NA first reported a position in GSK in Q2 2015 and held it in 23 quarters. The position peaked at $839K in Q2 2020. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Cadence Bank NA reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Cadence Bank NA sold 8,178 GSK shares in Q3 2022, an estimated $445K.
Cadence Bank NA first reported a position in GSK in Q2 2015 and held it in 23 quarters.
Cadence Bank NA's GSK position peaked at $839K in Q2 2020.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Cadence Bank NA's 13F filing for Q3 2022, filed 27 Oct 2022.